ACAD Operating Cash Flow (Statement)

Acadia Pharmaceuticals Inc · Operating Cash Flow (Statement)

ACAD logo

ACAD Operating Cash Flow (Statement)

Latest reported$194.30M
ACAD TTM Cash from Operations (-$20.69M → $194.30M)
High-resolution chart · PNG

ACAD operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Acadia Pharmaceuticals Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
194,300,000
123,494,000
109,836,000
198,948,000
187,906,000
148,963,000
157,719,000
202,727,000
80,526,000
63,714,000
16,702,000
-92,541,000
-34,313,000
-55,639,000
-114,035,000
-113,301,000
-129,638,000
-141,840,000
-125,660,000
-130,028,000
-135,757,000
-147,313,000
-136,166,000
-138,385,000
-134,443,000
-135,957,000
-151,130,000
-160,502,000
-183,931,000
-186,409,000
-167,470,000
-158,286,000
-174,407,000
-192,432,000
-217,857,000
-251,151,000
-242,012,000
-239,857,000
-210,408,000
-181,941,000
-164,532,000
-137,661,000
-121,795,000
-104,874,000
-90,505,000
-77,598,000
-66,434,000
-58,898,000
-50,889,000
-39,366,000
-31,769,000
-27,801,000
-23,632,000
-22,988,000
-21,633,000
-20,674,000
-19,540,000
-20,020,000
-19,897,000
-9,955,000
-8,305,000
-9,358,000
-10,703,000
-24,080,000
-33,219,000
-6,891,000
-13,727,000
-17,226,000
-21,408,000
-57,610,000
-64,869,000
-66,465,000
-63,764,000
-61,250,000
-54,926,000
-53,597,000
-52,564,000
-47,676,000
-41,418,000
-35,912,300
-30,068,000
-27,959,800
-20,262,600
-19,932,800
-18,854,200
-17,058,000
-20,693,400
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.